Homepage
Discover Cellply
Unravelling immune system function, one cell at a time
VivaCyte® LAUNCH
Cellply launches its end-to-end single cell potency characterization platform VivaCyte®
Advanced Therapies Week 2024
During Advanced Therapies Week 2024 in Miami we officially launched our flagship product, VivaCyte®.
Our platform integrates multiple technologies to streamline cell therapy discovery and development.
Read the press release to find out more details!
Our flagship product
Introducing the VivaCyte platform
One of a kind analytical system for discovery and process development of cell therapies
VivaCyte enables the characterization of immune cells at an unprecedented resolution and scale, with a fully automated analysis, from sample preparation to image processing.
- 100+ samples per run
- 1,000+ single cells per sample
- many assays per cell